Terms: = Gastric cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Treatment
15 results:
1. Characteristic Mutational Damages in gastric and Colorectal Adenocarcinomas.
Yermekova S; Orazgaliyeva M; Goncharova T; Rakhimbekova F; Kaidarova D; Shatkovskaya O
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3939-3947. PubMed ID: 38019254
[TBL] [Abstract] [Full Text] [Related]
2. High In Vitro and In Vivo Activity of BI-847325, a Dual MEK/Aurora Kinase Inhibitor, in Human Solid and Hematologic cancer Models.
Vuaroqueaux V; Musch A; Peille AL; Kelter G; Weichert L; Metz T; Hendriks HR; Fiebig HH
Cancer Res Commun; 2023 Oct; 3(10):2170-2181. PubMed ID: 37830744
[TBL] [Abstract] [Full Text] [Related]
3. KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer.
Shimozaki K; Shinozaki E; Yamamoto N; Imamura Y; Osumi H; Nakayama I; Wakatsuki T; Ooki A; Takahari D; Ogura M; Chin K; Watanabe M; Yamaguchi K
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1273-1283. PubMed ID: 35438321
[TBL] [Abstract] [Full Text] [Related]
4. Diagnosis and treatment of ERBB2-Positive Metastatic Colorectal cancer: A Review.
Strickler JH; Yoshino T; Graham RP; Siena S; Bekaii-Saab T
JAMA Oncol; 2022 May; 8(5):760-769. PubMed ID: 35238866
[TBL] [Abstract] [Full Text] [Related]
5. Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib.
Bornemann L; Schuster M; Schmitz S; Sobczak C; Bessen C; Merz SF; Jöckel KH; Haverkamp T; Gunzer M; Göthert JR
BMC Cancer; 2020 Jul; 20(1):650. PubMed ID: 32660441
[TBL] [Abstract] [Full Text] [Related]
6. Targeting nras-Mutant cancers with the Selective STK19 Kinase Inhibitor Chelidonine.
Qian L; Chen K; Wang C; Chen Z; Meng Z; Wang P
Clin Cancer Res; 2020 Jul; 26(13):3408-3419. PubMed ID: 32156748
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer.
Wang G; He Y; Sun Y; Wang W; Qian X; Yu X; Pan Y
Clin Transl Oncol; 2020 Jun; 22(6):813-822. PubMed ID: 31587152
[TBL] [Abstract] [Full Text] [Related]
8. Translating genomic profiling to gastrointestinal cancer treatment.
Harada K; Mizrak Kaya D; Shimodaira Y; Song S; Baba H; Ajani JA
Future Oncol; 2017 Apr; 13(10):919-934. PubMed ID: 28067073
[TBL] [Abstract] [Full Text] [Related]
9. Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer.
Lennerz JK; van der Sloot KWJ; Le LP; Batten JM; Han JY; Fan KC; Siegel CA; Srivastava A; Park DY; Chen JH; Sands BE; Korzenik JR; Odze RD; Dias-Santagata D; Borger DR; Khalili H; Iafrate AJ; Lauwers GY
Int J Colorectal Dis; 2016 May; 31(5):973-982. PubMed ID: 27026089
[TBL] [Abstract] [Full Text] [Related]
10. Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer.
Gao JH; Wang CH; Tong H; Wen SL; Huang ZY; Tang CW
Sci Rep; 2015 Nov; 5():16382. PubMed ID: 26567773
[TBL] [Abstract] [Full Text] [Related]
11. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.
Nishida T; Blay JY; Hirota S; Kitagawa Y; Kang YK
Gastric Cancer; 2016 Jan; 19(1):3-14. PubMed ID: 26276366
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine.
Warneke VS; Behrens HM; Haag J; Balschun K; Böger C; Becker T; Ebert MP; Lordick F; Röcken C
Diagn Mol Pathol; 2013 Sep; 22(3):127-37. PubMed ID: 23846438
[TBL] [Abstract] [Full Text] [Related]
13. Farnesylcysteine methyltransferase activity and Ras protein expression in human stomach tumor tissue.
Han ES; Oh HY; Ha KW; Han BS; Hong SM; Han JW; Hong S; Noh SH; Lee HW
Arch Pharm Res; 1998 Aug; 21(4):378-84. PubMed ID: 9875463
[TBL] [Abstract] [Full Text] [Related]
14. [Immunohistological study on ras and myc oncogene products in pancreatic cancer].
Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243
[TBL] [Abstract] [Full Text] [Related]
15. Interferon-induced phenotypic changes in human tumor cells relative to the effects of interferon on c-ras oncogene expression.
Brouty-Boyé D; Wybier-Franqui J; Nardeux P; Daya-Grosjean L; Andeol Y; Suarez HG
J Interferon Res; 1986 Oct; 6(5):461-71. PubMed ID: 2433360
[TBL] [Abstract] [Full Text] [Related]
